Pazopanib, a novel multitargeted kinase inhibitor, shows potent in vitro antitumor activity in gastric cancer cell lines with FGFR2 amplification
Seung Tae Kim, Hye Lim Jang, Su Jin Lee, Jeeyun Lee, Yoon La Choi, Kyoung Mee Kim, Jeonghee Cho, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Masakazu Yashiro, Won Ki Kang, Joon Oh Park
Research output: Contribution to journal › Article › peer-review
36Scopus
citations
Fingerprint
Dive into the research topics of 'Pazopanib, a novel multitargeted kinase inhibitor, shows potent in vitro antitumor activity in gastric cancer cell lines with FGFR2 amplification'. Together they form a unique fingerprint.